# Overall survival with \[177Lu\]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overall-survival-with-177lu-lu-psma-617-versus-cabazitaxel-in-metastatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael S. Hofman,Louise Emmett,Shahneen Sandhu,Amir Iravani,James P Buteau,Anthony M. Joshua,Jeffrey C. Goh,David A. Pattison,Thean Hsiang Tan,Ian Kirkwood,Siobhan Ng,Roslyn J. Francis,Craig Gedye,Natalie Rutherford,Andrew Weickhardt,Andrew M. Scott,Sze-Ting Lee,Edmond M. Kwan,Arun Azad,Shakher Ramdave,Andrew Redfern,W A Macdonald,Alex Guminski,Edward Hsiao,Wei Chua,Peter Lin,Alison Yan Zhang,Martin R. Stockler,Scott Williams,Andrew Martin,Ian D. Davis,Tim Akhurst,Ramin Alipour,Dale L. Bailey,Patricia Banks,Alexis Beaulieu,Louise Campbell,Megan Crumbaker,Nattakorn Dhiantravan,Anis Hamid,Mohammad B. Haskali,Terry Hung,Grace Kong,Nick Lawrence,Jeremy Lewin,Michael McCarthy,Kate Moodie,Declan G. Murphy,Andrew Nguyen,David Pook,Aravind Ravi Kumar,Paul Roach,Peter Roselt,Javad Saghebi,Geoffrey Schembri,Lavinia Spain,Shalini Subramaniam,Sue Ping Thang,Paul Thomas,Ben Tran,Roslyn E. Wallace,Sonia Yip |
| Citations | 210 |
| DOI | 10.1016/s1470-2045(23)00529-6 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4389210100 |
| PMID | 38043558 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Michael S. Hofman](https://scholariq.org/researchers/michael-s-hofman/)
- [W A Macdonald](https://scholariq.org/researchers/w-a-macdonald/)
- [Grace Kong](https://scholariq.org/researchers/grace-kong/)
- [Shahneen Sandhu](https://scholariq.org/researchers/shahneen-sandhu/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.